PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 28, 2026Value in Health Regional Issues0 citationsOpen Access

Cost-Effectiveness Analysis of the Messenger RNA Test (Aptima®) Compared With the Polymerase Chain Reaction DNA Test for Human Papillomavirus Screening From the Colombian Perspective

View Full Paper
PBPaula Benítez-OspinaUniversidad El BosqueJAJairo Amaya-GuíoUniversidad Nacional de ColombiaCNCristian E. NavarroUniversidad de Antioquia

Key Points

  • This analysis aims to evaluate the cost-effectiveness of the Aptima test relative to the PCR DNA test for HPV screening.
  • Comparative cost-effectiveness analysis based on screening strategies
  • Focus on women over 30 years old
  • Contextual analysis within the Colombian health system
  • Aptima test demonstrates increased cost-effectiveness compared to PCR, improving screening efficiency
  • Implementation of the Aptima test can optimize resource allocation in HPV prevention
  • Overall reduction in long-term healthcare costs associated with HPV-related conditions

Abstract

The Aptima test represents a cost-effective strategy for screening HPV infection in women over 30 years of age, compared with the polymerase chain reaction DNA test, within the context of the Colombian health system.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Benítez-Ospina et al. (2026) studied this question.

synapsesocial.com/papers/69f04e08727298f751e72031https://doi.org/10.1016/j.vhri.2026.101634
Ask AI
Helpful
Bookmark
Share
View Full Paper